Insmed Inc INSM

NAS: INSM | ISIN: US4576693075 19/12/2025

174,84 USD (+4,98%)

(+4,98%) 19/12/2025

Grafiek Insmed Inc

Grafiek Insmed Inc

1 dag1d 4,98%
1 week1w -11,21%
1 maand1m -15,51%
3 maanden3m 20,55%
6 maanden6m 65,85%
1 jaar1j 147,68%
5 jaar5j 385,94%

Insmed Inc in het nieuws

Toon enkel gratis nieuws

17 december 2025 · Insmed Provides Clinical and Business Update · Persbericht

4 december 2025 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

18 november 2025 · European Commission Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union · Persbericht

13 november 2025 · Insmed Strengthens Communities Worldwide During Fourth Annual Global Day of Good · Persbericht

5 november 2025 · Insmed To Present at November and December 2025 Investor Conferences · Persbericht

30 oktober 2025 · Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update · Persbericht

23 oktober 2025 · Insmed Ranks No. 1 on Science's 2025 Top Biopharma Employers List · Persbericht

17 oktober 2025 · CHMP Recommends EU Approval of BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis · Persbericht

16 oktober 2025 · Insmed to Present Multiple Analyses from Phase 3 ASPEN Study at the American College of Chest Physicians Annual Meeting 2025 · Persbericht

15 oktober 2025 · Insmed to Host Third-Quarter 2025 Financial Results Conference Call on Thursday, October 30, 2025 · Persbericht

Profiel Insmed Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.insmed.com

Hoofdzetel: Bridgewater, New Jersey Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe